Endologix Inc., of Irvine, Calif., reported revenues in-line with expectations Thursday, as it discussed pipeline progress and a new agreement with Boston Scientific for China. Sean Lavin, analyst at BTIG, pointed to how the company has controlled expenses and maintained guidance as positives. "We maintain our Buy and applaud the progress made this quarter," Lavin wrote.